Abraxis Bioscience Inc. New (ABII) Stock Quote

Detailed Quote for Abraxis Bioscience Inc. New (ABII)

close 52 Week Information

52 Week High

October 15, 2010

Close: 78.62

52 Week Low

October 30, 2009

Close: 31.20

Today

5d

1m

3m

1y

more

Last Price
N/A

Change $
N/A

Change %
N/A

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
N/A

High
N/A

Low
N/A

Prev Close
N/A

Last Trade
N/A

Volume
0

52 Wk Hi
78.62

52 Wk Low
31.20

Market Cap
N/A

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
40,465,643

EPS (TTM)
-1.87

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Abraxis Bioscience Inc. New (ABII)

Sector News | Topic News

Tags for Abraxis Bioscience Inc. New

Research stocks or mutual funds related to Abraxis Bioscience Inc. New by keywords or tags. Find companies that have a similar focus to ABII. The keywords below have been associated to ABII by either user submission or electronic means.

biotech research pharmaceutical branding cgmp pharmaceutical bioscience pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment pharmaceutical patents pharma regulations pharmaceutical research and development pharmaceutical manufacturing company pharma marketing pharmaceutical software pharma manufacturing pharma license novartis pharmaceuticals generic products pharmaceutical cro active pharmaceutical ingredients pharmaceutical sales top selling products pharmaceutical distributors pharma in licensing biotech corporation pharmaceutical development pharmaceutical reports pharmaceutical consultant biotech pharmaceutical patent Drugs massengill products pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation regulatory pharmaceutical pharmaceutical article pfizer pharmaceuticals contract pharmaceutical pharmaceutical consulting pharmaceutical industry pharmaceutical sale medical device market pharmaceutical magazines pharmaceutical studies pharmaceutical advances pharmaceutical distributor pharmaceutical out licensing pharmaceutical business development

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.